Gemtuzumab Ozogamicin is a promising post-remission therapy for acute myeloid leukemia

被引：2
|
作者：
El Kinge, Abdul Rahman
Hatourn, Hassan A.
Mahfouz, Rami A. [2 ]
Otrock, Zaher K. [2 ]
Jabbour, Elias [3 ]
Kantarjian, Hagop [3 ]
Bazarbachi, Ali [1 ]
机构：
[1] Amer Univ Beirut, Med Ctr, Dept Internal Med, Bone Marrow Transplantat Program, Beirut, Lebanon
[2] Amer Univ Beirut, Med Ctr, Dept Pathol & Lab Med, Beirut, Lebanon
[3] Univ Texas MD Anderson Canc Ctr, Dept Leukemia, Houston, TX 77030 USA
来源：
LEUKEMIA RESEARCH | 2009年 / 33卷 / 04期
关键词：
ACUTE MYELOGENOUS LEUKEMIA; RELAPSE; CHEMOTHERAPY; PROPOSAL;
D O I：
10.1016/j.leukres.2008.05.006
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：565 / 566
页数：2
相关论文
共 50 条
  • [41] Comparison of the impact of two post-remission therapy regimens on cardiac events in acute myeloid leukemia patients undergoing allogeneic hematopoietic stem cell transplantation
    Hayakawa, Jin
    Nakasone, Hideki
    Minakata, Daisuke
    Fujiwara, Shin-ichiro
    Gomyo, Ayumi
    Akahoshi, Yu
    Komiya, Yusuke
    Harada, Naonori
    Ugai, Tomotaka
    Kameda, Kazuaki
    Wada, Hidenori
    Ishihara, Yuko
    Kawamura, Koji
    Sakamoto, Kana
    Sato, Miki
    Terasako-Saito, Kiriko
    Kikuchi, Misato
    Kimura, Shun-ichi
    Kanda, Junya
    Kako, Shinichi
    Kanda, Yoshinobu
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2022, 116 (02) : 239 - 247
  • [42] Gemtuzumab Ozogamicin as First-Line Treatment in Patients Aged 70 Years or Older With Acute Myeloid Leukemia
    McHayleh, Wassim
    Foon, Kenneth
    Redner, Robert
    Sehgal, Rajesh
    Raptis, Anastasios
    Agha, Mounzer
    Luong, Minh
    Schlesselman, James J.
    Boyiadzis, Michael
    CANCER, 2010, 116 (12) : 3001 - 3005
  • [43] Is it time to revisit standard post-remission therapy?
    Stone, Richard M.
    BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY, 2012, 25 (04) : 437 - 441
  • [44] High-dose cytarabine plus gemtuzumab ozogamicin as consolidation therapy in patients with favorable- or intermediate-risk acute myeloid leukemia
    Oya, Shuki
    Ozawa, Hidetoshi
    Morishige, Satoshi
    Maehiro, Yoshimi
    Umeda, Masahiro
    Takaki, Yusuke
    Fukuyama, Toshinobu
    Yamasaki, Yoshitaka
    Nakamura, Takayuki
    Yamaguchi, Maki
    Aoyama, Kazutoshi
    Mouri, Fumihiko
    Nagafuji, Koji
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2024, 120 (03) : 297 - 304
  • [45] A phase I dose-escalation study of clofarabine in combination with fractionated gemtuzumab ozogamicin in patients with refractory or relapsed acute myeloid leukemia
    Foster, Matthew C.
    Amin, Chirag
    Voorhees, Peter M.
    Van Deventer, Hendrik W.
    Richards, Kristy L.
    Ivanova, Anastasia
    Whitman, Jennifer
    Chiu, Wingkeung Michael
    Barr, Nathan D.
    Shea, Thomas
    LEUKEMIA & LYMPHOMA, 2012, 53 (07) : 1331 - 1337
  • [46] Comparison of microtransplantation, chemotherapy and allogeneic transplantation in post-remission therapy for Philadelphia chromosome-positive acute lymphoblastic leukemia
    Cai, Bo
    Sun, Qiyun
    Qiao, Jianhui
    Yu, Changlin
    Hu, Kaixun
    Liu, Tieqiang
    Li, Bingxia
    Huang, Yajing
    Wang, Yi
    Zuo, Hongli
    Dong, Zheng
    Lei, Yaqing
    Liu, Zhiqing
    Yao, Bo
    Li, Caixia
    Ai, Huisheng
    Guo, Mei
    AMERICAN JOURNAL OF CANCER RESEARCH, 2020, 10 (11): : 3852 - 3866
  • [47] Gemtuzumab ozogamicin for relapsed or primary refractory acute myeloid leukemia in children-the Polish Pediatric Leukemia and Lymphoma Study Group experience
    Pawinska-Wasikowska, Katarzyna
    Czogala, Malgorzata
    Skoczen, Szymon
    Surman, Marta
    Rygielska, Monika
    Ksiazek, Teofila
    Pac, Agnieszka
    Wieczorek, Aleksandra
    Skalska-Sadowska, Jolanta
    Samborska, Magdalena
    Wachowiak, Jacek
    Chaber, Radoslaw
    Tomaszewska, Renata
    Szczepanski, Tomasz
    Zielezinska, Karolina
    Urasinski, Tomasz
    Moj-Hackemer, Malgorzata
    Kalwak, Krzysztof
    Kozlowska, Marta
    Irga-Jaworska, Ninela
    Balwierz, Walentyna
    Bukowska-Strakova, Karolina
    FRONTIERS IN IMMUNOLOGY, 2023, 14
  • [48] A Case of Therapy-Related Acute Myeloid Leukemia With a Normal Karyotype After Sustained Molecular Complete Remission of Acute Promyelocytic Leukemia
    Park, Sang Hyuk
    Chi, Hyun-Sook
    Cho, Young-Uk
    Jang, Seongsoo
    Park, Chan-Jeoung
    Lee, Je-Hwan
    ANNALS OF LABORATORY MEDICINE, 2014, 34 (01) : 68 - 70
  • [49] A comparative evaluation of gemtuzumab ozogamicin plus daunorubicin-cytarabine and other treatments for newly diagnosed acute myeloid leukemia
    Ashaye, Ajibade O.
    Khankhel, Zarmina
    Xu, Yingxin
    Fahrbach, Kyle
    Mokgokong, Ruth
    Orme, Michelle E.
    Lang, Kathryn
    Cappelleri, Joseph C.
    Mamolo, Carla
    FUTURE ONCOLOGY, 2019, 15 (06) : 663 - 681
  • [50] Overexpression of annexin A5 might guide the gemtuzumab ozogamicin treatment choice in patients with pediatric acute myeloid leukemia
    Zhang, Nan
    Zhang, Ying
    Zhang, Ping
    Lou, Shifeng
    Chen, Ying
    Li, Huan
    Zeng, Hanqing
    Shen, Yan
    Deng, Jianchuan
    THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY, 2020, 12
12345